Loading...
Loading...
Analysts at Piper Jaffray downgraded MAKO Surgical
MAKO from “overweight” to “neutral.” The target price for MAKO Surgical has been raised from $26 to $30. MAKO Surgical's shares closed at $29.70 yesterday.
Analysts at Barclays downgraded ARIAD Pharmaceuticals
ARIA from “overweight” to “underweight.” The target price for ARIAD Pharmaceuticals has been lowered from $25 to $4. ARIAD Pharmaceuticals' shares closed at $5.83 yesterday.
Nomura downgraded Maxim Integrated Products
MXIM from “buy” to “neutral.” The target price for Maxim Integrated Products is set to $28. Maxim Integrated's shares closed at $29.22 yesterday.
Analysts at Ascendiant Capital downgraded Leapfrog Enterprises
LF from “buy” to “neutral.” The target price for Leapfrog Enterprises has been lowered from $12 to $8. Leapfrog's shares closed at $9.15 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: DowngradesAnalyst RatingsConsumer DiscretionaryHealth CareHealth Care EquipmentLeisure ProductsTop Downgrades
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in